Celldex Therapeutics unveiled promising results from a chronic hives treatment on Monday, and the biotech stock rocketed to an 11-month high.

The post Celldex Stock Hits 11-Month High, Up 19%, On A Promising New Hives Treatment appeared first on Investor’s Business Daily.